100% remote: Medical/Health Researcher (m/f/n) – Freelance – on hold

  • Position zu besetzen ab 15. Februar 2021
  • Permanent-ID OCR-FL-1206
  • Branche Pharma
  • Beschäftigungsform Freelance/ Contracting
  • Standort Deutschland
  • Kategorien Beschäftigungsform, Branche, Freelance/Contracting, Pharma

Development of evidence generation strategies and (abbreviated) value dossiers for two COVID-19 treatments

Project description:

The service is requested as part of the company’s efforts to develop therapeutic options to treat or prevent COVID-19 infections and related complications (target indications). The project has the ultimate purpose to provide equitable access to two of the company’s COVID-19 treatments under emergency conditions and to guide their most appropriate use. More specifically, it will inform the development of evidence generation strategies and (abbreviated) value dossiers for two COVID-19 treatments, in light of public and government scrutiny, potential supply shortages requiring benefit stratification, non-standard Health Technology Assessment (HTA) pathways, and frequently sub-optimal pandemic response plans on national/regional and local levels.

Task description:

Independent interpretation and consolidation of HTA reports, market research, existing internal analyses and publically available data on the evidence requirements of payers, HTA agencies and pandemic response teams to develop evidence generation strategies and (abbreviated) value dossiers for two COVID-19 treatments in the target indications, including:

  • Evaluation and assessment of payer insights on evidence needs in relevant treatment and (emergency) care pathways for the two COVID-19 treatments in their target indications based on extensive external expertise in Health Economics & Outcomes Research (HEOR)
  • Conduct and roll-out of literature reviews on the health economic value of key competitor products in our target indications
  • Evaluation and assessment of value and cost/benefit of utilizing the above compounds in different treatment settings / patient populations in order to inform public health priorities of governments, Non-governmental organizations (NGOs) and pandemic response teams on national, regional or local levels
  • Developing and communication of patient-reported outcomes (PRO) strategies and relevant indirect treatment comparisons for the two compounds in question in their target indications to demonstrate product value to payers and HTA agencies based on extensive external methodological knowledge and expertise in HEOR
  • Evaluation and design of required value demonstration studies to quantify and demonstrate the health-economic benefit of the two compounds in question in their target indication relative to previously identified payer value-drivers
  • Development and delivery of key elements of the value story and (abbreviated) dossier to demonstrate and communicate the value of the two compounds to payers, HTA agencies and pandemic response teams on national, regional and local levels and to provide results for integrating them into pandemic response plans

…based on the above consolidated data and extensive existing external HEOR knowledge in terms of Excel sheets and presentations.

  • All results will be delivered to the HEOR lead for the two products for review and approval.
  • Consult…
    • the HEOR lead on designing, developing and implementing a global long-term value demonstration strategy for two COVID-19 treatments in question
    • the HEOR lead in the development of a health economic model for the two compounds in question
    • the Epidemiology lead on the development of Real-World-Evidence (RWE) strategies, which take the needs of payers, HTA agencies and pandemic response teams into account

…based on approved results of the above analyses and extensive external HEOR knowledge

 

Qualifications:

  • Learning agility to pick asset from „ground zero“.
  • Senior HEOR manager with at least 6-10 years HEOR experience, ideally in the COVID-space or from vaccines
  • Strong track record in value generation, demonstration and/or communication
  • Highly experienced in conducting health economics/outcomes research across multiple specialty disciplines (e.g. patient reported outcomes, health economic modelling, real world data generation)
  • Disease understanding of COVID-19 or vaccine or infectious diseases applicable to COVID-19 is desirable
  • In-depth understanding of healthcare provision and relevant stakeholders (payers, organized customer groups, HTA agencies and influencers), ideally already in the COVID-space
  • Track record in evidence based medicine standards and of health economics/outcomes research methodology (such as patient reported outcomes, health economic modelling, real world data generation)
  • Key global pricing & market access regulations and practices, health technology assessment, economics of healthcare systems, pharma product development and brand strategy development
  • Technical expertise and knowledge of relevant analytical methodologies across all relevant topics/areas
  • Excellent communication and influencing skills as well as project management and organizational capabilities are required

Additional Information

Location: remote (Ingelheim)

Project start: asap, latest March 2021

Duration: 6 months

Availability: 4-5 days / week

Remote: 100%

PDF herunterladen